BRK-B vs CFND
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
CFND exhibits critical financial weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe operational distress. The company lacks almost all fundamental reporting metrics, including P/E, ROE, and Debt/Equity, suggesting a lack of transparency or operational viability. Technical performance is overwhelmingly bearish, with a 1-year price decline of 58.8% and a technical trend score of 0/100. Given the micro-cap size and absence of growth or profitability, the asset presents an extremely high-risk profile.
Compare Another Pair
Related Comparisons
BRK-B vs CFND: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and C1 Fund Inc. (CFND) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.